HealThink at 9th Cancer Conference

HealThink is very glad to support and participate in the 9th Cancer Conference, organized by Boussias on September 24th in Athens. Kelly Avgitidou, Medical, Value & Access Lead of HealThink, will share our extensive experience and present “Oncology Drugs: Advancements, Evaluation and Access”.

HealThink at InnoHealth Forum 2024

HealThink, as a health innovation- focused company, will participate in InnoHealth Forum 2024 which will be held on September 20th and 21st and our Scientific Director, Panos Stafylas, will have the honor to moderate the Round Table “Digital Medicine”.

Δ.Ε.Θ.: Παρουσία της HealThink στο περίπτερο του ΕΚΑΠΤΥ

Αποτελεί ιδιαίτερη τιμή για τη HealThink, η πρόσκληση της Προέδρου του ΕΚΑΠΤΥ, κας Ρίτας Πικρού - Μωραϊτάκη προς τον Επιστημονικό Διευθυντή της HealThink, να συμμετάσχει στις παρουσιάσεις που διοργανώνονται στα πλαίσια της Δ.Ε.Θ.   

RWD and RWE in regulatory decision-making

As many medicines regulatory agencies have expressed increased willingness to consider RWE to support claims of efficacy or effectiveness as well as of safety, the data and methods used to generate RWE are changing.

HealThink at InnoHealth Satellite Event #2

Μία πολύ ενδιαφέρουσα εκδήλωση οργανώνεται σήμερα στη Θεσσαλονίκη με θέμα "Διαχείριση Δεδομένων στην Υγεία (Health Data) & Ψηφιακό Φάρμακο".

HealThink at 9th HTA Conference

The 9th HTA conference organized by BOUSSIAS was successfully completed with the participation of distinguished speakers and a large number of participants. The Scientific Director of HealThink, Panos Stafylas, participated in the conference by coordinating..